Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF

Published 2019 View Full Article

Authors

Keywords

EGF, Experimental allergic encephalomyelitis, Multiple sclerosis

Journal

JOURNAL OF NEUROIMMUNOLOGY

Volume 332, Issue -, Pages 224-232

Publisher

Elsevier BV

Online

2019-05-09

DOI

10.1016/j.jneuroim.2019.05.006

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started